AU781133B2 - Nitrosated and nitrosylated proton pump inhibitors, compositions and methods of use - Google Patents
Nitrosated and nitrosylated proton pump inhibitors, compositions and methods of use Download PDFInfo
- Publication number
- AU781133B2 AU781133B2 AU32196/00A AU3219600A AU781133B2 AU 781133 B2 AU781133 B2 AU 781133B2 AU 32196/00 A AU32196/00 A AU 32196/00A AU 3219600 A AU3219600 A AU 3219600A AU 781133 B2 AU781133 B2 AU 781133B2
- Authority
- AU
- Australia
- Prior art keywords
- group
- compound
- nitric oxide
- composition
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/433—Thidiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12211199P | 1999-02-26 | 1999-02-26 | |
US60/122111 | 1999-02-26 | ||
PCT/US2000/002524 WO2000050037A1 (fr) | 1999-02-26 | 2000-02-25 | Inhibiteurs de la pompe a proton nitroses et nitrosyles, compositions et procedes d'utilisation |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2005202553A Division AU2005202553A1 (en) | 1999-02-26 | 2005-06-10 | Nitrosated and nitrosylated proton pump inhibitors, compositions and methods of use |
Publications (2)
Publication Number | Publication Date |
---|---|
AU3219600A AU3219600A (en) | 2000-09-14 |
AU781133B2 true AU781133B2 (en) | 2005-05-05 |
Family
ID=22400684
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU32196/00A Ceased AU781133B2 (en) | 1999-02-26 | 2000-02-25 | Nitrosated and nitrosylated proton pump inhibitors, compositions and methods of use |
AU2005202553A Abandoned AU2005202553A1 (en) | 1999-02-26 | 2005-06-10 | Nitrosated and nitrosylated proton pump inhibitors, compositions and methods of use |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2005202553A Abandoned AU2005202553A1 (en) | 1999-02-26 | 2005-06-10 | Nitrosated and nitrosylated proton pump inhibitors, compositions and methods of use |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1154771A4 (fr) |
JP (1) | JP2002537336A (fr) |
AU (2) | AU781133B2 (fr) |
CA (1) | CA2362930C (fr) |
WO (1) | WO2000050037A1 (fr) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0002476D0 (sv) | 2000-06-30 | 2000-06-30 | Astrazeneca Ab | New compounds |
AU2002342917A1 (en) * | 2001-11-19 | 2003-06-10 | Altana Pharma Ag | Reversible proton pump inhibitors for the treatment of airway disorders |
TW200403072A (en) * | 2002-01-23 | 2004-03-01 | Upjohn Co | Combination therapy for the treatment of bacterial infections |
PL370839A1 (en) * | 2002-03-14 | 2005-05-30 | Altana Pharma Ag | Use of proton pump inhibitors for the treatment of airway disorders |
US20050148634A1 (en) * | 2002-03-29 | 2005-07-07 | Zeria Pharmaceutical Co., Ltd | 1-N-Aminobenzimidazole derivatives |
CA2480832A1 (fr) * | 2002-04-05 | 2003-10-23 | Nitromed, Inc. | Donneurs de monoxyde d'azote, compositions et procedes d'utilisation, applications correspondantes |
JP4634144B2 (ja) * | 2002-08-01 | 2011-02-16 | ニコックス エスエー | ニトロソ化プロトンポンプ阻害剤、組成物および使用方法 |
FR2845915B1 (fr) * | 2002-10-21 | 2006-06-23 | Negma Gild | Utilisation du tenatoprazole pour le traitement du reflux gastro-oesophagien |
FR2845917B1 (fr) * | 2002-10-21 | 2006-07-07 | Negma Gild | Composition pharmaceutique associant le tenatoprazole et un anti-inflammatoire |
CA2554271A1 (fr) * | 2004-02-10 | 2005-08-25 | Santarus, Inc. | Combinaison d'un inhibiteur de la pompe a protons, d'un tampon et d'un medicament anti-inflammatoire non steroidien |
TW200606163A (en) | 2004-04-22 | 2006-02-16 | Eisai Co Ltd | Imidazopyridine compound |
US20070015782A1 (en) | 2005-04-15 | 2007-01-18 | Eisai Co., Ltd. | Benzimidazole compound |
US9040564B2 (en) | 2005-04-28 | 2015-05-26 | Eisai R&D Management Co., Ltd. | Stabilized composition |
WO2007016677A2 (fr) | 2005-08-02 | 2007-02-08 | Nitromed, Inc. | Composes antimicrobiens promoteurs d'oxyde nitrique, compositions et procedes d'utilisation |
JP5075254B2 (ja) | 2011-01-07 | 2012-11-21 | スノーデン株式会社 | 胃酸及びガストリンの産生を抑制する乳酸菌 |
US20230293457A1 (en) * | 2020-02-26 | 2023-09-21 | Shanghaitech University | Application of disulfiram in coronavirus resistance |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5599794A (en) * | 1992-04-24 | 1997-02-04 | Aktiebolaget Astra | Synergistic combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05117268A (ja) * | 1991-10-22 | 1993-05-14 | Yoshitomi Pharmaceut Ind Ltd | ピリジン化合物 |
SG49853A1 (en) * | 1993-08-16 | 2001-07-24 | Novartis Ag | Novel macrolides and the use thereof |
JPH10501254A (ja) * | 1994-06-10 | 1998-02-03 | ビイク グルデン ロンベルク ヒェーミッシェ ファブリーク ゲゼルシャフト ミット ベシュレンクテル ハフツング | 置換アリールアルキルチオアルキルチオピリジン |
CZ288278B6 (en) * | 1994-06-10 | 2001-05-16 | Byk Gulden Lomberg Chem Fab | Thiopyridines and process of their preparation |
DE4420523A1 (de) * | 1994-06-13 | 1995-12-14 | Cassella Ag | Verwendung von NO-freisetzenden Verbindungen zur Behandlung und Vorbeugung von systemischen Entzündungssyndromen |
SE9500422D0 (sv) * | 1995-02-06 | 1995-02-06 | Astra Ab | New oral pharmaceutical dosage forms |
US5703073A (en) * | 1995-04-19 | 1997-12-30 | Nitromed, Inc. | Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs |
US6132768A (en) * | 1995-07-05 | 2000-10-17 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Oral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitors |
EP0941102A1 (fr) * | 1996-11-22 | 1999-09-15 | The Procter & Gamble Company | Compositions et methodes pour traiter des troubles gastro-intestinaux |
UA57056C2 (uk) * | 1996-12-20 | 2003-06-16 | Бік Гулден Ломберг Хеміше Фабрік Гмбх | Імідазопіридазини та лікарський засіб |
EP0983263A1 (fr) * | 1997-05-30 | 2000-03-08 | Dr. Reddy's Research Foundation | Nouveaux benzimidazoles utilises comme agents antiulcereux, leur procede de preparation et compositions pharmaceutiques les contenant |
-
2000
- 2000-02-25 AU AU32196/00A patent/AU781133B2/en not_active Ceased
- 2000-02-25 JP JP2000600648A patent/JP2002537336A/ja active Pending
- 2000-02-25 EP EP00910039A patent/EP1154771A4/fr not_active Withdrawn
- 2000-02-25 CA CA2362930A patent/CA2362930C/fr not_active Expired - Fee Related
- 2000-02-25 WO PCT/US2000/002524 patent/WO2000050037A1/fr active IP Right Grant
-
2005
- 2005-06-10 AU AU2005202553A patent/AU2005202553A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5599794A (en) * | 1992-04-24 | 1997-02-04 | Aktiebolaget Astra | Synergistic combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic |
US5629305A (en) * | 1992-04-24 | 1997-05-13 | Astra Aktiebolag | Synergistic combination of a substance with gastric acid secretion inhibiting effect and an acid degradable antibiotic |
Also Published As
Publication number | Publication date |
---|---|
JP2002537336A (ja) | 2002-11-05 |
CA2362930C (fr) | 2010-10-05 |
CA2362930A1 (fr) | 2000-08-31 |
EP1154771A4 (fr) | 2005-04-20 |
EP1154771A1 (fr) | 2001-11-21 |
AU2005202553A1 (en) | 2005-07-07 |
AU3219600A (en) | 2000-09-14 |
WO2000050037A1 (fr) | 2000-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2005202553A1 (en) | Nitrosated and nitrosylated proton pump inhibitors, compositions and methods of use | |
AU772188B2 (en) | Nitrosated and nitrosylated H2 receptor antagonist compounds, compositions and methods of use | |
US20070179150A1 (en) | Nitrosated proton pump inhibitors, compositions and methods of use | |
US7332505B2 (en) | Nitrosated and nitrosylated proton pump inhibitors, compositions and methods of use | |
US6693122B2 (en) | Nitrosated and nitrosylated potassium channel activators, compositions and methods of use | |
US20020016322A1 (en) | Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositons and methods of use | |
AU5701699A (en) | Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use | |
AU6133499A (en) | Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use | |
JP2007238458A (ja) | 新規なイソキノリン誘導体及びこれを含有する医薬 | |
US20020143007A1 (en) | Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use | |
AU2004202027B2 (en) | Nitrosated and nitrosylated H2 receptor antagonist compounds, compositions and methods of use | |
AU2004201585B2 (en) | Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use | |
JPH1036367A (ja) | ピリジン化合物 |